Journal of Addiction Medicine

Article	Citations
Response to Martins et al.	62
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder	60
Effectiveness and Safety of Varenicline for Smoking Cessation: An Overview and Meta-analysis	45
Management of Xylazine Withdrawal in a Hospitalized Patient: A Case Report	39
In-hospital Substance Use Policies: An Opportunity to Advance Equity, Reduce Stigma, and Offer Evidence-based Addiction Care	38
Nonopioid Substance Use among Patients Who Recently Initiated Office-based Buprenorphine Treatment	36
Medication Initiation, Patient-directed Discharges, and Hospital Readmissions Before and After Implementing Guidelines for Opioid Withdrawal Management	33
Patient Perceptions of Integrating Meditation-based Interventions in Office-based Opioid Treatment with Buprenorphine: A Mixed-methods Survey	32
Induction to Methadone 80 mg in the First Week of Treatment of Patients Who Use Fentanyl: A Case Series From an Outpatient Opioid Treatment Program	28
The Incidence and Disparities in Use of Stigmatizing Language in Clinical Notes for Patients With Substance Use Disorder	26
A Clinical Guide to Support the Implementation of Addiction Consult Services and the Value of Teaching and Technical Assistance	25
Responses to a “Typical” Morning Dose of Kratom in People Who Use Kratom Regularly: A Direct-Observation Study	22
Twelve-month Treatment Retention and Associated Factors: A Comparison of 2 Medically Assisted Therapy Clinics in Dar es Salaam, Tanzania	21
The Social Context of Unhealthy Alcohol Use Among Emergency Department Patients: A Cross Sectional Study	21
Inpatient Opioid Use Disorder Treatment by Generalists is Associated With Linkage to Opioid Treatment Programs After Discharge	20
A Case of Acute Opioid Withdrawal after Liposuction Surgery in a Patient on Extended-release Buprenorphine	20
Low Dose Buprenorphine Induction With Full Agonist Overlap in Hospitalized Patients With Opioid Use Disorder: A Retrospective Cohort Study	19
Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine	18
A Plea From People Who Use Drugs to Clinicians: New Ways to Initiate Buprenorphine Are Urgently Needed in the Fentanyl Era	18
Social Determinants of Health and Continuity of Medications for Opioid Use Disorder Among Patients Receiving Treatment in Rural Primary Care Settings	17
Commentary on “Application of an Existing Syndromic Surveillance System to Quantify Possible Cases of Opioid-associated Amnestic Syndrome in Massachusetts”	17
The Role of Primary Care in the Initiation of Opioid Use Disorder Treatment in Statewide Public and Private Insurance	17
Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration	16
Synthetic Cathinone–Induced Myocarditis and Psychosis: A Case Report	16
North Carolina Medicaid System Perspectives on Substance Use Disorder Treatment Policy Changes During the COVID-19 Pandemic	16

Rapid Transition to Buprenorphine in a Patient With Methadone-Related QTc Interval Prolongation	16
Alcohol-related Opioid Overdose Deaths in Minnesota Between 2011 and 2020: Trends by Sex	16
Evaluation and Management of Buprenorphine Extended-Release Injection Thrombophlebitis: A Case Report	16
Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations	16
Association of State Drug Laws with Nonmedical Use of Prescription Medications in Adolescents	15
Letter to the Editor (RE: Polles et al)	15
Implementation of a Naloxone Best Practice Advisory Into an Electronic Health Record	15
Permanent Methadone Treatment Reform Needed to Combat the Opioid Crisis and Structural Racism	15
Factors Associated With Severe Bacterial Infections in People Who Inject Drugs: A Single-center Observational Study	14
Hepatitis C Virus Cascade of Care Among Perinatal Patients in Maine Diagnosed With Opioid Use Disorder, 2015–2020	14
Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women’s Prison Facility, 2016–2019	14
Buprenorphine Monoproduct for Buprenorphine/Naloxone Tolerability Problems: Navigating Stigma for Patient-centered Addiction Care without Guideline Support	14
Outcomes of Emergency Department Patients With Opioid Use Disorder Utilizing a Virtual Addiction Bridge Clinic: A Case Series	14
Feasibility of a Brief Intervention to Decrease Harmful Alcohol Use Among Methadone Maintenance Treatment Clients in Shanghai: A Randomized Controlled Trial	14
Racial-ethnic Differences in Reasons for Misuse of Prescription Medications Among US Adults	13
Satisfaction With Opioid Agonist Treatment: The Compelling Need for Multidimensional, Patient-centered, Patient-reported Experience Measures	13
Commentary on Ajazi et al (2021) Re-analysis of the X:BOT Trial	13
Regular Kratom (Mitragyna speciosa Korth.) Use and Its Association With Endoplasmic Reticulum Stress Response	12
Response to the Federation of State Physician Health Program's Commentary	12
Medicaid Prescription Cap Policies: Another Structural Barrier to Medication for Opioid Use Disorder	12
Gabapentin Use During Pregnancy and Lactation With and Without Concurrent Opioid Exposure: Considerations and Future Directions	12
Managing Benzodiazepine Withdrawal—The Emperor’s New Clothes	11
Virtual Care in an Outpatient Subspecialty Substance Use Disorder Treatment Program	11
Predictors of the Rate of Illicit Fentanyl Metabolism in a Cohort of Pregnant Individuals	11
Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis	11
Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial	11
Readmissions Among Patients With Surgically Managed Drug Use Associated-Infective Endocarditis Before and After the Implementation of an Addiction Consult Team: A Retrospective, Observational Analysis	10
Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV	10
Struggling With Recovery From Opioids: Who Is at Risk During COVID-19?	10
Is Gastric Bypass a Risk Factor for Complicated Alcohol Withdrawal? Case Report and Literature Review	10
Statewide Trends in Buprenorphine Prescribing in Rural and Nonrural Vermont: Analysis of Population-based Patient Pharmacy Claims	10
Association of Urine Fentanyl Concentration With Severity of Opioid Withdrawal Among Patients Presenting to the Emergency Department	9
Blood Oxygenation and Heart Rate Changes After Diamorphine Intravenous Injection During Opioid Agonist Treatment for Outpatients With Heroin Dependence	9
Initiatives to Support the Transition of Patients With Substance Use Disorders From Acute Care to Community-based Services Among a National Sample of Nonprofit Hospitals	9
Prescription Drug Misuse with Alcohol Coingestion among US Adolescents: Youth Experiences, Health-related Factors, and Other Substance Use Behaviors	9
Under the Skin: The Relationship Between Subcutaneous Injection and Skin Infections Among People Who Inject Drugs	9
Trends in Substance Use Disorder-related Admissions at a Safety-net Hospital, 2008 – 2020	9
The Pharmacological Management of Ketamine Use Disorder: A Systematic Review	9
Associations of Methadone and BUP/NX Dose Titration Patterns With Retention in Treatment and Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: Secondary Analysis of the OPTIMA Stud	9
Cannabis Use Disorder Treatment Preferences: A Pilot Survey in Current Users of Cannabis	8
Identifying Barriers to Buprenorphine Treatment for Patients with Opioid Use Disorder Among Anesthesiologists and Pain Practitioners: A Survey Study	8
A Nationwide Survey Study of Recovery Community Centers Supporting People in Recovery From Substance Use Disorder	8
Low-dose Induction of Buprenorphine in Pregnancy: A Case Series	8
Efficacy of Brief Interventions for Comorbid Substance Misuse in Patients on Opioid Agonist Treatment: A Systematic Review and Meta-analysis	8
Extended-release Naltrexone Is Not Linked to Hepatotoxicity in Adults Experiencing Homelessness and Alcohol Use Disorder	8
Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a R	8
Initiating Long-acting Injectable Naltrexone: Procedure for a Second Attempt After a First Attempt Fails	8
Use of Video Directly Observed Therapy and Characteristics Associated With Use Among Patients Treated With Buprenorphine in an Office-based Setting	8
Global and Regional Burden and Trend of Neoplasms Attributable to Alcohol Consumption in the Past 3 Decades	8
“Just Be There”: Desired Partner Behaviors Among Pregnant People Living With Opioid Use Disorder, a Qualitative Study	8

Causes of Death in the 12 Months After Hospital Discharge Among Patients With Opioid Use Disorder	8
Characterizing Substance Use Disorders Among Transgender Adults Receiving Care at a Large Urban Safety Net Hospital	8
Withdrawal-like Symptoms in Problematic Pornography Use: A Scoping Review	7
A Brief Intervention on Alcohol Use Disorder Is Associated With Treatment Access for Inpatients With Alcohol-Associated Liver Disease	7
Patients' Perspectives on Discontinuing Buprenorphine for the Treatment of Opioid Use Disorder	7
Methamphetamine Use in Psychiatric Emergency Services and Among Asian American and Pacific Islander Populations	7
Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices	7
Off-Label Use of Lamotrigine and Naltrexone in the Treatment of Ketamine Use Disorder: A Case Report	7
Predictive Models to Assess Risk of Persistent Opioid Use, Opioid Use Disorder, and Overdose	7
Trajectories of Opioid Misuse and Opioid Use Disorder Among Adults With Chronic Pain and HIV: An Observational Study	7
Generative Artificial Intelligence Tools in Medicine Will Amplify Stigmatizing Language	7
An Intervention to Improve Evidence-Based Nicotine Prescribing by Primary Care Physicians	7
Supervised Disulfiram Should Be Considered First-line Treatment for Alcohol Use Disorder	7
Association of Opioid Use Disorder–Related Service Trajectories during Pregnancy and Postpartum Health Service Use: A Group-Based Multitrajectory Modeling Study	6
A Naturalistic Study of Individuals Involved in the Justice System Who Experienced Both Formulations of Extended-release Buprenorphine	6
Cannabis Legalization and Adolescent Use of Electronic Vapor Products, Cannabis, and Cigarettes	6
Parosmia Is Positively Associated With Problematic Drinking, as Is Phantosmia With Depressive Symptoms	6
Medication for Addiction Treatment and Postpartum Health Care Utilization Among Pregnant Persons With Opioid Use Disorder	6
Patterns of Substance Use During Early Pregnancy and Associations With Behavioral Health Characteristics	6
Increased Wound Prevalence in those Exposed to Xylazine and Fentanyl Compared to Those Exposed to Fentanyl: An Observational Study	6
Evaluation of Low-dose Buprenorphine Initiation With Buprenorphine Buccal Films in Hospitalized Patients: A Retrospective Cohort Study	6
Disruption of Opioid Treatment Program Services Due to an Extreme Weather Event: An Example of Climate Change Effects on the Health of Persons Who Use Drugs	6
False-Positive Phosphatidylethanol Results Due to Blood Transfusion and Implications in the Process of Liver Transplantation Selection	6
Drug-induced Liver Injury Due to Medications for Alcohol Use Disorder: Results From the DILIN Prospective Study	6
Fentanyl Absorption, Distribution, Metabolism, and Excretion: Narrative Review and Clinical Significance Related to Illicitly Manufactured Fentanyl	6
Response to: “Chronic Pain Associated Alcohol Use Disorder among Participants in a Small Clinical Trial”	6
Buprenorphine Salivary Gland Accumulation Sustaining High Oral Fluid Exposure and Increasing the Risk of Streptococcus mutans Biofilm Formation	6
Individuals Reporting Past 3-month Smoked Stimulant Use Are Placed at Risk for Infection and Injury Amid COVID-19	6
Longitudinal Associations Between Use of Tobacco and Cannabis Among People Who Smoke Cigarettes in Real-world Smoking Cessation Treatment	6
New Alcohol-related Condition Diagnoses Are Associated With Opioid Tapers Among Patients Receiving Long-term Opioid Therapy	6
Heterogeneity in Prescription Opioid Misuse Motives by Age in Adolescents and Young Adults in the United States	6
Medications for Alcohol Use Disorder among Birthing People with an Alcohol-related Diagnosis	6
Malignant Catatonia in the Setting of Acute Methamphetamine and Cocaine Intoxication	6
5-Day Injectable Extended-release Buprenorphine Initiation in Non–opioid-tolerant Individuals in a Carceral Setting: A Case Series	6
Kava Withdrawal Treated With Phenobarbital—A Case Report and Literature Review	6
Subcutaneous Extended-release Buprenorphine Depot Misdiagnosed as an Abscess Resulting in Incision and Drainage and Disruption of Opioid Use Disorder Treatment	5
Substance Use Disorder Care in Skilled Nursing Facilities: Characterizing Resident Experiences	5
“Meeting Patients Where They're at”: Clinician Perspectives on Integration of Family Planning Services into Office-Based Addiction Treatment	5
Defining Opioid-related Problems Using a Health Care Safety Net Institution’s Inpatient Electronic Health Records: Limitations of Diagnosis-based Definitions	5
Initiation of Extended-release Depot Buprenorphine in a Patient Subject to a Community Treatment Order for Both Antipsychotic and Opioid Agonist Treatments	5
Prevalence and Correlates of Past Year Ecstasy/MDMA Use in the United States	5
Peer Support Specialists: An Underutilized Resource in the Criminal Justice System for Opioid Use Disorder Management?	5
Federation of State Physician Health Programs' Response to Helping the Helpers	5
Low-dose Buprenorphine Initiation in Hospitalized Adults With Opioid Use Disorder: A Retrospective Cohort Analysis	5
Decline in Prenatal Buprenorphine/Naloxone Fills during the COVID-19 Pandemic in the United States	5
Adapting Contingency Management for Hospitalized Patients with Stimulant Use Disorder	5
Opioid Use Behaviors Among People With Disability in the United States: An Analysis of the National Survey on Drug Use and Health	5
Correlates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail	5
Assessing Childhood Maltreatment Exposure in Patients Without and With a Diagnosis of Substance Use Disorder	5
Logistical Facilitators and Barriers to PrEP Implementation in Methadone Clinic Settings: Provider and Staff Perspectives	5
Successful Transition from Fentanyl to Buprenorphine in a Community-based Withdrawal Management Setting	5
Polysubstance Use in Adults With Opioid Use Disorder Receiving Buprenorphine Maintenance	5
Criminal Justice Referrals to Cannabis Use Disorder Treatment among Adolescents and Young Adults following Recreational Cannabis Legalization in the United States	5
Associations between Patient Experience and Addiction Treatment Facility Services: Results of the Addiction Treatment Locator, Assessment, and Standards Surveys	5
Findings From Implementing a Patient Experience Survey in a Quality Measurement System for Substance Abuse Disorder Treatment Facilities in 6 States	5
Provider Perceptions Toward Extended-Release Buprenorphine for Treatment of Opioid Use Disorder	5
Associations of Current and Remitted Cannabis Use Disorder With Health-related Quality of Life and Employment Among US Adults	5
The Need for Multidisciplinary Hospital Teams for Injection Drug Use-related Infective Endocarditis	5
A Brief Online Training to Address Pharmacists' Willingness to Dispense Buprenorphine	5
Injection of Methamphetamine Has Increased in Boston, Massachusetts: 5 Waves of Centers for Disease Control and Prevention State Surveillance Data	5
The Need to Rule Out Intranasal Self-administration of Buprenorphine-Naloxone Combinations Before Prescribing Buprenorphine Without Naloxone	5
Research With Women Who Use Drugs: Applying a Trauma-informed Framework	4
One Fictional Opioid Overdose in Eighteenth-century England and One Attempted Opioid Overdose in Nineteenth-century America	4
Trauma Prevalence and Its Association With Health-Related Quality of Life in Pregnant Persons with Opioid Use Disorder	4
Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial	4
Drive Time to Addiction Treatment Facilities Providing Contingency Management across Rural and Urban Census Tracts in 6 US States	4
Utility of the Global Appraisal of Individual Needs Recommendation and Referral Report for Substance Use Diagnosis, Treatment Planning, and Placement	4
Association Between Variables and Transitions Among No Opioid Use, Opioid Use, and Subsequent Dropout Among Participants on Methadone Treatment: A Retrospective Study Utilizing a Multistate Model	4
Injecting Opioid Use Disorder Treatment in Jails and Prisons: The Potential of Extended-release Buprenorphine in the Carceral Setting	4
Perception of Resource Allocations to Address the Opioid Epidemic	4
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19	4
Exploration Into Patterns of Cannabis Use Across Pregnancy and Postpartum	4
Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration	4
Phencyclidine Positivity on Urine Drug Screening in Patients Treated for Alcohol Withdrawal on a Dual-diagnosis Medically Assisted Withdrawal Unit	4
Educational Studies Examining Knowledge of Substance Use Disorders and Career Aspirations Among Medical Trainees in an Inner-City Hospital	4
Trends in Characteristics of Prescription Opioid-related Poisonings among Older Adults in the United States, 2015–2021	4
Harnessing the Power of Social Media to Understand the Impact of COVID-19 on People Who Use Drugs During Lockdown and Social Distancing	4
Use of Practices to Reduce of Sudden Unexpected Infant Death among Caregivers of Opioid Exposed Newborns	4
The Other Infodemic: Media Misinformation about Involuntary Commitment for Substance Use	4
Letter in Reply	4

Longitudinal Associations Between Use of Tobacco and Cannabis Among People Who Smoke Cigarettes in Real-world Smoking Cessation Treatment: Erratum	4
Discordance Between Insurance Coverage of Antiviral Medications and Nicotine Replacement Therapy Among Individuals With Human Immunodeficiency Virus Who Smoke	4
Parent Guidance on Alcohol Use for Youth With Chronic Medical Conditions	4
Pharmacotherapies for Adults With Alcohol Use Disorders: A Systematic Review and Network Meta-analysis	4
Integrating Text Messaging in a Low Threshold Telebuprenorphine Program for New York City Residents with Opioid Use Disorder during COVID-19: A Pilot Randomized Controlled Trial	4
Letter in Reply in Barnes et al	4
30-Month Impact of Medications for Opioid Use Disorder on Acute Care Utilization in Rural Communities	4
Adverse Childhood Experiences Are Associated With History of Overdose Among Patients Presenting for Outpatient Addiction Care	4
All a-BORG! The Dangerous Drinking Trend Steamrolling Across Social Media and College Campuses	4
Disparities in Perinatal and Emergency Care Receipt Among Women With Perinatal Opioid Use Disorder in Medicaid, 2007 to 2012	4